Central cardiovascular effects of tacrine in the conscious dog: A role for catecholamines and vasopressin release

European Journal of Pharmacology

Volumn 348, Issue 2-3, 1998, Pages 191-198

  Allal, Cuider ^a   Lazartigues, Eric ^a   Tran, Marie Antoinette ^a   Brefel Courbon, Christine ^a   Gharib, Claude ^b   Montastruc, Jean Louis ^a   Rascol, Olivier ^a  

^a INSERM   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

Blood pressure; Central; Cholinergic system; Muscarinic receptor; Noradrenaline; Tacrine

Indexed keywords

ADRENALIN; ATROPINE; CATECHOLAMINE; CHOLINESTERASE INHIBITOR; METHYLSCOPOLAMINE; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; NORADRENALIN; TACRINE; VASOPRESSIN;

ARTICLE; CARDIOVASCULAR EFFECT; CATECHOLAMINE RELEASE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DOG; DOSE RESPONSE; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; VASOPRESSIN RELEASE;

EID: 0032496075     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00143-5     Document Type: Article

References (30)

1. Allain H., Maruelle L., Beneton C., Rouault G., Belliard S. Poussées d'hypertension artérielle lors d'un traitement par tacrine. Presse Méd. 25:1996;1388-1389.
2. Ally A., Wilson L.B., Nobrega A.C.L., Mitchell J.H. Cardiovascular effects elicited by central administration of physostigmine via M2 muscarinic receptors in conscious cats. Brain Res. 677:1995;268-276.
3. Bassant M.H., Jazat-Poindessous F., Lamour Y. Metabolic response to tacrine (THA) and physostigmine in the aged rat brain. J. Cereb. Blood Flow Metab. 15:1995;1093-1102.
4. Bisset G.W., Chowdrey H.S. A cholinergic link in the reflex release of vasopressin by hypotension in the rat. J. Physiol. 354:1984;523-545.
5. Brefel C., Lazartigues E., Tran M.A., Gauquelin G., Geelen G., Gharib C., Montastruc J.L., Montastruc P., Rascol O. Central cardiovascular effects of acetylcholine in the conscious dog. Br. J. Pharmacol. 116:1995;2175-2182.
6. Brezenoff H.E. Centrally induced pressor responses to intravenous and intraventricular physostigmine evoked via different pathways. Eur. J. Pharmacol. 23:1973;290-292.
7. Brezenoff H.E., Giuliano R. Cardiovascular control by cholinergic mechanisms in the central nervous system. Annu. Rev. Pharmacol. Toxicol. 22:1982;341-381.
8. Brezenoff H.E., Rusin J. Brain acetylcholine mediates the hypertensive response to physostigmine in the rat. Eur. J. Pharmacol. 29:1974;262-266.
9. Buccafusco J.J. The role of central cholinergic neurons in the regulation of blood pressure and in experimental hypertension. Pharmacol. Rev. 48:1996;179-211.
10. Buccafusco J.J., Brezenoff H.E. Pharmacological study of a cholinergic mechanism within the rat posterior hypothalamic nucleus which mediates a hypertensive response. Brain Res. 165:1979;295-310.
11. Cain J. Hypertension associated with oral administration of physostigmine in a patient with Alzheimer's disease. Am. J. Psychiatry. 143:1986;910-912.
12. Caputi A.P., Camilleri B.H., Brezenoff H.E. Age-related hypotensive effect of atropine in unanesthetized spontaneously hypertensive rats. Eur. J. Pharmacol. 66:1980;103-109.
13. Caputi A.P., Rossi F., Carney K., Brezenoff H.E. Modulatory effect of brain acetylcholine on reflex-induced bradycardia and tachycardia in conscious rats. J. Pharmacol. Exp. Ther. 215:1980;309-316.
14. Davis K.L., Powchik P. Tacrine. Lancet. 345:1995;625-630.
15. Gheusi G., Bluthe R.M., Goodall G., Dantzer R. Ethological study of the effects of tetrahydroaminoacridine (THA) on social recognition in rats. Psychopharmacology. 114:1994;644-650.
16. Hori H., Haruta K., Nanki M., Sakamoto N., Uemura K., Matsubara T., Itoh K., Iguchi A. Pressor response induced by the hippocampal administration of neostigmine is suppressed by M1 muscarinic antagonist. Life Sci. 57:1995;1853-1859.
17. Krstic M.K., Djurkovic D. Cardiovascular response to intracerebroventricular administration of acetylcholine in rats. Neuropharmacology. 17:1978;341-347.
18. Lazartigues E., Freslon J.L., Tran M.A., Montastruc J.L., Rascol O. Cardiovascular effects of tacrine in anesthetized rats. Methods Find. Exp. Clin. Pharmacol. 18:1996;113.
19. Lee S.B., Kim S.Y., Sung K.W. Cardiovascular regulation by cholinergic mechanisms in rostral ventrolateral medulla of spontaneously hypertensive rats. Eur. J. Pharmacol. 205:1991;117-123.
20. Mesulam M.M., Geula C., Moran M.A. Anatomy of cholinesterase inhibition in Alzheimer's disease: effect of physostigmine and tetrahydroaminoacridine on plaques and tangles. Ann. Neurol. 22:1987;683-691.
21. Ozawa H., Uematsu T. Centrally mediated cardiovascular effects of intracisternal application of carbachol in anesthetized rats. Jpn. J. Pharmacol. 26:1976;339-346.
22. Özkutlu U., Onat F., Aslan A.N., Oktay S. Central muscarinic M2 cholinoceptors involved in cholinergic hypertension. Eur. J. Pharmacol. 250:1993;349-354.
23. Pazos A., Wiederhold K.H., Palacios J.M. Central pressor effects induced by muscarinic receptor agonists: evidence for a predominant role of the M2 receptor subtype. Eur. J. Pharmacol. 125:1986;63-70.
24. Pelat M., Lazartigues E., Tran M.A., Gharib C., Montastruc J.L., Rascol O. Characterization of the central muscarinic cholinoceptors involved in cholinergic pressor response in anesthetized dogs. Fundam. Clin. Pharmacol. 11:1997;188.
25. Rascol O., Montastruc J.L., Gauquelin G., Tran M.A., Geelen G., Gharib C., Montastruc P. Cardiovascular effects of central injection of acetylcholine in anesthetized dogs: a role for vasopressin release. Br. J. Pharmacol. 100:1990;471-476.
26. Summers W.K., Majovski L.V., Marsh G.M., Tachiki K., Kling A. Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. New Engl. J. Med. 315:1986;1241-1245.
27. Ulus I.H., Arslan B.Y., Savci V., Kiran B.K. Restoration of blood pressure by choline treatment in rats made hypotensive by haemorrhage. Br. J. Pharmacol. 116:1995;1911-1917.
28. Varagic V. The action of eserine on the blood pressure of the rat. Br. J. Pharmacol. 10:1955;349-353.
29. Wagstaff A.J., McTavish D. Tacrine - a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease. Drugs Aging. 6:1994;510-540.
30. Xiao Y.F., Brezenoff H.E. The role of M2 muscarinic receptors in the posterior hypothalamus in the pressor response to intracerebroventricularly injected neostigmine. Neuropharmacology. 27:1988;1061-1065.